Search
for
Sort by
Research 571–600 of 1000+
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Sebaceous gland atrophy due to seborrheic dermatitis in a patient with alopecia: A potential pitfall
- Therapeutic Intervention in Lichen Planus Pilar (LPP): Synergy of Low-Level Laser Therapy and Topical Corticosteroid
- Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome in a Saudi Child: A Case Report
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- Pityriasis rubra pilaris unveiling a case of a new onset hepatitis C infection
- THE EFFECT OF AUTOLOGOUS PLATELET RICH PLASMA (PRP) ON PATIENTS WITH ALOPECIA AREATA
- Subject Index
- Alopecia Universalis: an extremely rare but probable adverse effect of adalimumab
- The use of diphencyprone in dermatology: A retospective audit
- PHILADELPHIA DERMATOLOGICAL SOCIETY
- Comparison of Zn, Cu, and Fe Content in Hair and Serum in Alopecia Areata Patients with Normal Group
- S3909 Paradoxical Psoriasis and Alopecia Areata After the Use of Anti-TNF in a Patient With Crohn's Cisease
- A Dermoscopic Clue for the Diagnosis of Traction Alopecia: Peripilar Keratin Casts: Case Report
- The impact of alopecia areata on patients' daily lives: A study using social media in France
- Alopecia Neoplastica: A Manifestation of Metastatic Breast Cancer
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Reflectance confocal microscopy for scarring and non-scarring alopecia real-time assessment
- Trichothiodystrophy with Dysmyelination and Central Osteosclerosis
- KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Yellow dots in trichoscopy: relevance, clinical significance and peculiarities
- Hair loss in children.
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Denosumab-induced alopecia areata with lichenoid eruption
- Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- ALOPECIA ANDROGENÉTICA: MINOXIDIL ORAL VERSUS OUTRAS TERAPIAS MEDICAMENTOSAS